País: Kirguizistan
Idioma: rus
Font: Правительства Кыргызской Республики (Департамент лекарственного обеспечения и медицинской техники)
Мемантина гидрохлорид
Helba Ilac Ic ve Dis San. Tic. A.S. (Helba Ilac Ic ve Dis San. Tic. A.S.)
N06DX01
Memantine hydrochloride
10 мг
таблетки, покрытые пленочной оболочкой
№100
по рецепту
Merkez Laboratory Pharmaceutical and Trade Co. (Турция)
Блокатор глутаматных NMDA-рецепторов. Препарат, применяемый для лечения деменции
ПЖВЛС: нет
2019-12-13
vTBEPXAAIO flenapra*re 0fitililltlffi II Munu Kup .{xau ,roj ,, r4HCTpyK \Ufl,rro MEAT,TqIIHCKOMy IIPI{MEHBH}IIO JIEKAPCTBEHHOI o CPEACTBA AJITIEEA (Alceba) Topronoe Ha3BaHlre Arqe6a Mexayna1)oAHoe He[areHToBaHHoe Ha3BAHHe Menran'u.Is Jlexapr;rneuHaa Sopua Ta6rerru, noKpbITbIe nreHo'{Hofi o6oro'{roft, 10 ur. Cocran OlHa ra6le'ma coAepxl'IT oKmtwuoe Bet4ecm6o.' MeMaHTITHa rl'I.4poxJlopua 10 llr SCnOMAtzAnletbHde 6eu4ecm6a: IIeJIJIIOJIO3a MLIKpOKpI{CT€IJIJII{qeCKafl, KpeMHuq ALI oKclIA KoJIJror'IAHbtfi 6esnoAHblfi , TarEK, MalHI4g creapar llneHoqHafl o\onoqxa; Sepifilm rIeHKa IR 777 (Kollicoat IR noJrr.rgT'I{IeHrJII,IKoJleBbIe rpaSr - nonllMepu), nolUgeKcTpo3a, KaoJII4H 'rr{raHa II4or(crIA (E 1 7 1 )). HaTpr,Is KpocKapMeJIJIo3a, (uonunuuuJlcrll{proB ble, TsxeJrbrfi, MaKporoJI 400, Ouucanue 'Ia6:re1xu npoAontoBarofi $oplrbr c,qBo.rrKonsmyr:rofi noBepxHocrblo, IloKpblrrte nleHoqnofi o6onoqrofi 6e.rroro u.ru 6e;roro c xeJrroBarbrM orreHKoM IIBera, c pucrofi c o6ezx cropoH. Oapnr:lxorepaleBTutlecKafl rpytr[a flpenaparu AffI neqeHufl AeMeHI-lru. flpyrne rpenapaTbl AIfl neqenl4rl AeMeHU[I4' MerraaHruu. Ko,q A'IX l{06DX01 tDapuaxo.il oruqecKr{e csofi crsa @apmuxoxuHemuna Ilocle [pueMa BHyrpb 6srcrpo r4 norrHocrslo BcacblBaercfl. Maxcutua,rbHaq KoHueHTpauIu B lJIa3Me KpoBr4 Aocrllraerc.rr B TerreHr.re 2-6 qacoB. Csgsrteauue c 6e:rxaul4 IIrIa3MbI coc'raBrfle'I' 45%. [ocle nepopaJrbHoto npuenra 80% A036r oilpeAertqercrl B KpoBI4 B HeII3MeHeHHoM BuAe, frasusle vera6o,lnrbl MeMaKcr4Ha N-3,5-4auerl4n-rnyAaHTaH, cMelIraHHblfi usolrep 4- ut 6- rr{Apor(cr{MeMar{rr4Ha v 1-nurpoao 3,5-AurrteruJl-aAaMalrraH He o6laAaior NMDA- aHrarc)Huc'luqecrofi aKTHBHocrrro. IIpu HopMaJrbHofi rpynrqara roqeK I{yMynflIILIx MeMaKc}IHiI He orMerreuo. SnuMuuaUl,r.f, rrporeKaer 4nyxQasuo. Ttn cocraBJlf,er B cpe.(HeM n nepnoft (!ase 4-9 'r, uo n'ropofi Q*" - 40-65 .I. BgsoAurcfl IIpeI4MyuIecTBeHHo IIoTIKaMI'I (75-90%)' Ar qe6a uKa HeKgHKypeHrHbtM aHraroH1rcroM N-uerul-D-acraprar Q'{MDA)-peqen'ropoB, OKA3bIBACT 'Jrr{pypqee Ae[crBI{e Ha ilIyraMareprualec Llegiu el document complet